Abstract
AbstractThe anticancer activity of ginseng originated mainly from lipid‐soluble components. The hexane extract of ginseng marc (HEGM) showed a potent inhibitory activity on human hepatoma (HepG2, GI50 = 41.7 μg/ml) and breast (MCF‐7, GI50 = 54.4 μg/ml) cancer cell proliferation in vitro in a concentration‐dependent manner as did the hexane extract of ginseng (HEG), with GI50 values of 21.1 μg/ml in HepG2 and 41.2 μg/ml in MCF‐7. The water extract of ginseng (WEG) possessed a low anticancer activity against both cancer cell lines, but the hexane‐soluble fraction of WEG (HSF/WEG) showed a potent anticancer activity against HepG2 (GI50 = 38.7 μg/ml) and MCF‐7 cells (GI50 = 51.1 μg/ml). The hexane extraction in ginseng was a very promising protocol for the maximum recovery of the anticancer active components in high concentrations. Also the adoption of hexane extraction after water extraction of ginseng was successful in the effective utilization of the residual lipid‐soluble anticancer active components in ginseng marc.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
